Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-25-000663
Filing Date
2025-02-05
Accepted
2025-02-05 17:20:12
Documents
5
Effectiveness Date
2025-02-05

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20250207xs8.htm S-8 111203
2 EX-5.1 tmb-20250207xex5d1.htm EX-5.1 13017
3 EX-23.1 tmb-20250207xex23d1.htm EX-23.1 3984
4 EX-FILING FEES tmb-20250207xexfees.htm EX-FILING FEES 23981
5 GRAPHIC tmb-20250207xex5d1002.jpg GRAPHIC 4308
  Complete submission text file 0001558370-25-000663.txt   159546
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-284713 | Film No.: 25594440
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)